Twelve Points Wealth Management’s AbbVie ABBV Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.09M	Buy	5,002 +44	+0.9%	+$9.76K	0.24%	88
2025 Q4	$1.09M	Sell	4,958 -1,277	-20%	-$291K	0.25%	83
2025 Q3	$1.44M	Sell	6,235 -534	-8%	-$109K	0.36%	70
2025 Q2	$1.26M	Buy	6,769 +375	+6%	+$69.7K	0.34%	73
2025 Q1	$1.34M	Sell	6,394 -383	-6%	-$74.5K	0.36%	67
2024 Q4	$1.2M	Buy	6,777 +642	+10%	+$118K	0.35%	69
2024 Q3	$1.21M	Buy	6,135 +508	+9%	+$94.8K	0.38%	63
2024 Q2	$965K	Buy	5,627 +372	+7%	+$61.6K	0.34%	75
2024 Q1	$957K	Buy	5,255 +336	+7%	+$57.9K	0.35%	69
2023 Q4	$762K	Buy	4,919 +308	+7%	+$44.9K	0.36%	78
2023 Q3	$687K	Buy	4,611 +244	+6%	+$35.8K	0.34%	81
2023 Q2	$588K	Buy	4,367 +776	+22%	+$114K	0.31%	90
2023 Q1	$572K	Buy	3,591 +307	+9%	+$46.9K	0.33%	90
2022 Q4	$531K	Sell	3,284 -15	-0.5%	-$2.3K	0.36%	86
2022 Q3	$443K	Buy	3,299 +436	+15%	+$62.6K	0.34%	96
2022 Q2	$439K	Buy	2,863 +574	+25%	+$87.7K	0.34%	107
2022 Q1	$371K	Buy	2,289 +658	+40%	+$95.6K	0.28%	115
2021 Q4	$221K	Buy	+1,631	New	+$193K	0.18%	154